임상시험 트래커
추적 기업 30곳의 임상 6,982건 (국내 전체 이력 · 글로벌 진행 중). 출처: ClinicalTrials.gov
기업
50건 표시
- 1/2상모집 예정· Arthritis, RheumatoidA Study of BMS-986528 in Participants With Refractory Rheumatoid Arthritis
리드: BMS
- 1/2상모집 중· Antineutrophil Cytoplasmic Antibody-associated VasculitisCC-97540 in Patients With Antineutrophil Cytoplasmic Antibody-associated Vasculitis
협력: BMS
- 1/2상모집 중· SCHIZOPHRENIA 1 (Disorder)A PET/MRI Study of Cobenfy on Dopamine Transmission in Schizophrenia
협력: BMS
- 1/2상모집 중· Advanced Renal Cell Carcinoma (RCC)A Study to Evaluate the Safety, Tolerability, and Efficacy of Pumitamig Alone or in Combination With Ipilimumab or Cabozantinib in Participants With Advanced Renal Cell Carcinoma (RCC) (ROSETTA RCC-208)
리드: BMS · 협력: 바이오엔테크
- 1/2상모집 중· Hepatocellular Carcinoma (HCC)A Study to Evaluate the Safety and Tolerability of Pumitamig Alone or In Combination With Ipilimumab in Participants With First-Line Advanced or Unresectable Hepatocellular Carcinoma (HCC) (ROSETTA HCC-206)
리드: BMS · 협력: 바이오엔테크
- 1/2상모집 중· Relapsed/Refractory Small Cell Lung CancerA Study to Assess the Safety and Tolerability of BMS-986525 Alone and in Combination Therapy in Participants With Relapsed/Refractory Small Cell Lung Cancer
리드: BMS
- 1/2상모집 중· Solid TumoursA Phase 1/2a, First-in-human, Study of BMS-986517 in Participants With Advanced Solid Tumors
리드: BMS
- 1/2상모집 중· Peripheral T Cells Lymphoma (PTCL)A Platform Trial Evaluating New Drugs or Combination in R/R Peripheral T-cell Lymphomas
협력: 애브비, BMS
- 1/2상모집 중· Advanced Solid TumorsA Study of BMS-986482 Alone or as Combination Therapy in Participants With Advanced Solid Tumors
리드: BMS
- 1/2상모집 중· Advanced Solid TumorsA Study of BMS-986490 With or Without Bevacizumab in Advanced Solid Tumors
리드: BMS
- 1/2상모집 중· Anemia, Sickle CellA Study to Evaluate BMS-986470 in Healthy Volunteers and Participants With Sickle Cell Disease
리드: BMS
- 1/2상모집 중· Childhood CancerOptimal Precision TherapIes to CustoMISE Care in Childhood and Adolescent Cancer
협력: BMS
- 1/2상모집 중· Relapsed/Refractory Non-Hodgkin LymphomaA Study to Assess BMS-986458 Alone and in Combination With Anti-lymphoma Agents in Relapsed/Refractory Non-Hodgkin Lymphomas
리드: BMS
- 1/2상모집 중단 (진행 중)· Untreated Myelodysplastic SyndromeOral Azacitidine Combined With Venetoclax in Previously Untreated Higher-risk Myelodysplastic Syndromes
협력: 애브비, BMS
- 1/2상모집 중단 (진행 중)· Relapsed or Refractory T-cell LymphomasA Study to Assess the Safety, Tolerability, Efficacy, and Drug Levels of BMS-986369 (Golcadomide) in Participants With Relapsed or Refractory T-cell Lymphomas in Japan (GOLSEEK-3)
리드: BMS
- 1/2상모집 중단 (진행 중)· Atypical Teratoid Rhabdoid TumorTazemetostat+Nivo/Ipi in INI1-Neg/SMARCA4-Def Tumors
협력: BMS
- 1/2상모집 중단 (진행 중)· Advanced Solid TumorsA Study of BMS-986449 With and Without Nivolumab in Participants With Advanced Solid Tumors
리드: BMS
- 1/2상모집 중단 (진행 중)· Multiple MyelomaCOMbination Regimens in MM Post AHCT to elimiNate MRD Utilizing IbERdomide
협력: BMS
- 1/2상모집 중단 (진행 중)· T-Cell Large Granular Lymphocyte LeukemiaOral Azacitidine for the Treatment of Relapsed or Refractory T-cell Large Granular Lymphocytic Leukemia
협력: BMS
- 1/2상모집 중단 (진행 중)· Highly Sensitized Prospective Kidney Transplant RecipientsCarfilzomib and Belatacept for Desensitization
협력: BMS
- 1/2상모집 중단 (진행 중)· Prostate CancerAndrogen Deprivation, With or Without pTVG-AR, and With or Without T-Cell Checkpoint Blockade, in Patients With Newly Diagnosed, High-Risk Prostate Cancer
협력: BMS, 리제네론
- 1/2상모집 중단 (진행 중)· Highly Sensitized Prospective Kidney Transplant RecipientsDaratumumab and Belatacept for Desensitization
협력: BMS
- 1/2상모집 중· Cervical CancerA Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors
리드: BMS
- 1/2상모집 중단 (진행 중)· Metastatic Urothelial CarcinomaCombination of Ipi/Nivo Plus Sacituzumab Govitecan in Metastatic Cisplatin Ineligible Urothelial Carcinoma Patients
협력: BMS, 길리어드
- 1/2상모집 중단 (진행 중)· GlioblastomaUltrasound-based Blood-brain Barrier Opening and Albumin-bound Paclitaxel and Carboplatin for Recurrent Glioblastoma
협력: BMS
- 1/2상모집 중단 (진행 중)· MelanomaA Study of Nivolumab and Hydroxychloroquine or Nivolumab/Ipilimumab and Hydroxychloroquine in Advanced Melanoma
협력: BMS
- 1/2상모집 중단 (진행 중)· Metastatic Colon AdenocarcinomaSX-682 and Nivolumab for the Treatment of RAS-Mutated, MSS Unresectable or Metastatic Colorectal Cancer, the STOPTRAFFIC-1 Trial
협력: BMS
- 1/2상모집 중단 (진행 중)· Primary MyelofibrosisA Study of Fedratinib in Japanese Subjects With DIPSS (Dynamic International Prognostic Scoring System)- Intermediate or High-risk Primary Myelofibrosis (PMF), Post-polycythemia Vera Myelofibrosis (Post-PV MF), or Post-essential Thrombocythemia Myelofibrosis (Post-ET MF)
리드: BMS
- 1/2상모집 중단 (진행 중)· Advanced CancerA Trial to Evaluate Safety and Tolerability of TST001 in Advanced or Metastatic Solid Tumors
협력: BMS
- 1/2상모집 중단 (진행 중)· MesotheliomaPhase 1/2 Trial of Gavo-cel (TC-210) in Patients With Advanced Mesothelin-Expressing Cancer
협력: BMS
- 1/2상모집 중단 (진행 중)· Prostate CancerNivolumab and BMS-986253 for Hormone-Sensitive Prostate Cancer (MAGIC-8)
협력: BMS
- 1/2상모집 중단 (진행 중)· Prostate CancerCombination of Nivolumab Immunotherapy With Radiation Therapy and Androgen Deprivation Therapy
협력: BMS
- 1/2상모집 중· Hodgkin LymphomaNivolumab With Ruxolitinib in Relapsed or Refractory Classical Hodgkin Lymphoma
협력: BMS
- 1/2상모집 중단 (진행 중)· Esophageal CancerSafety and Feasibility of Irradiation and Nivolumab in Esophageal Cancer (INEC)
협력: BMS
- 1/2상모집 중단 (진행 중)· Grade 3a Follicular LymphomaNivolumab and Lenalidomide in Treating Patients With Relapsed or Refractory Non-Hodgkin or Hodgkin Lymphoma
협력: BMS
- 1/2상모집 중단 (진행 중)· Hodgkin LymphomaA(B)VD Followed by Nivolumab as Frontline Therapy for Higher Risk Patients With Classical Hodgkin Lymphoma (HL)
협력: BMS
- 1/2상모집 중단 (진행 중)· Triple-Negative Breast CancerCisplatin Plus Romidepsin & Nivolumab in Locally Recurrent or Metastatic Triple Negative Breast Cancer (TNBC)
협력: BMS
BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.